ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1014

Is Radiographic Axial Involvement Associated with Syndesmophyte Development After 2 Years in PsA Patients?

Manouk de Hooge1, Alla Alexeevna Ishchenko2, Serge Steinfeld3, Adrien NZEUSSEU TOUKAP4, Dirk Elewaut5, Rik Lories6, Filip Van den bosch7 and Kurt de Vlam8, 1Ghent University Hospital, Luxembourg, Luxembourg, 2University Hospitals Leuven, Sint-Stevens-Woluwe, Belgium, 3Clinique Saint-Jean, Brussels, Belgium, 4Cliniques Universitaires Saint-Luc, Brussels, Belgium, 5Department of Rheumatology, Ghent University Hospital, Belgium, VIB-UGent Center for Inflammation Research, Ghent University, Heusden, Belgium, 6KU Leuven, Leuven, Belgium, 7Department of Internal Medicine and Paediatrics, Ghent University and VIB Centre for Inflammation Research, Ghent, Belgium, 8University Hospitals Leuven, Leuven, Belgium

Meeting: ACR Convergence 2022

Keywords: Cohort Study, Imaging, Psoriatic arthritis, radiography

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: There is an ongoing debate on axial involvement in psoriatic arthritis (PsA). This study, using clinical and radiographical definitions of axial involvement, investigated the association between axial involvement and new syndesmophytes development over 2 years in patients with PsA.

Methods: Patients originated from the Belgian Epidemiological Psoriatic Arthritis Study (BEPAS), a prospective multicentre cohort involving 17 Belgian rheumatology practices. Recruitment was from December 2012 until July 2014. Patients were included when fulfilling the Classification criteria for Psoriatic Arthritis (CASPAR). Axial involvement included several definitions (see figure 1). The treating did the clinical work up. Two calibrated central readers evaluated radiographic damage by assessing the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) for the presence of syndesmophytes and assessed the modified New York criteria (mNY) for the presence of sacroiliitis. Readers assessed spinal and pelvic radiographs separately and were blinded for time sequence, clinical data, and information from other obtained images (radiographs of the hands and feet). Generalized estimating equation models on vertebral unit level were used, taking into account that multiple corners belong to a single patient. All definitions of axial involvement were evaluated, only odds ratios (OR) with a p< 0.05 were reported.

Results: In total 461 patients were included in BEPAS. Mean age was 52.79±12.29 years and 43.0% (n=198) were female; average disease duration was 8.5 ± 9.3 years and approximately 34% of the patients reported inflammatory axial pain. From 150 patients 2 years follow-up of spinal radiographs were obtained. From the clinical definitions of axial involvement none were associated with the development of syndesmophytes in 2 years. Axial involvement was associated with syndesmophyte formation when defined as ‘mNY+ reader consensus’ (OR 3.72 (CI 1.06-13.06)). Although few patients with PsA developed syndesmophytes after 2 years, conditional probability analysis suggests that those patients meeting the mNY criteria for axial involvement have a higher chance of developing syndesmophytes (Table 1).

Table 1. Conditional probability table for axial involvement defined as radiographic sacroiliitis (mNY+ reader consensus) and the development of syndesmophytes over 2 years follow-up.

mNY+ reader consensus New syndesmophytes at 2 years n P (newSYND/axial involvement)
0 0 3446 P (newSYND/0) = 34/3480 = 0.0098
0 1 34
1 0 116 P (newSYND/1) = 4/120 = 0.0333
1 1 4
0=absent, 1=present

Conclusion: The likelihood of syndesmophyte formation in PsA is low and is more likely to be associated with axial involvement determined radiographically, particularly in the context of high CRP.

Supporting image 1


Disclosures: M. de Hooge, None; A. Ishchenko, None; S. Steinfeld, None; A. NZEUSSEU TOUKAP, None; D. Elewaut, AbbVie, Eli Lilly, Galapagos, Novartis, UCB Pharma; R. Lories, None; F. Van den bosch, AbbVie, Lilly, Galapagos, Janssen, Merck, Novartis, Pfizer, UCB, Amgen, Bristol-Myers Squibb(BMS), Celgene; K. de Vlam, UCB, Eli Lilly, Pfizer, AbbVie/Abbott, Merck/MSD, johnson and johnson.

To cite this abstract in AMA style:

de Hooge M, Ishchenko A, Steinfeld S, NZEUSSEU TOUKAP A, Elewaut D, Lories R, Van den bosch F, de Vlam K. Is Radiographic Axial Involvement Associated with Syndesmophyte Development After 2 Years in PsA Patients? [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/is-radiographic-axial-involvement-associated-with-syndesmophyte-development-after-2-years-in-psa-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-radiographic-axial-involvement-associated-with-syndesmophyte-development-after-2-years-in-psa-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology